ATE276757T1 - Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung - Google Patents

Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung

Info

Publication number
ATE276757T1
ATE276757T1 AT96923259T AT96923259T ATE276757T1 AT E276757 T1 ATE276757 T1 AT E276757T1 AT 96923259 T AT96923259 T AT 96923259T AT 96923259 T AT96923259 T AT 96923259T AT E276757 T1 ATE276757 T1 AT E276757T1
Authority
AT
Austria
Prior art keywords
pct
compositions
fiber segments
production
methods
Prior art date
Application number
AT96923259T
Other languages
English (en)
Inventor
Robert M Carr Jr
John F Cavallaro
Lisa M Bryant
David W Donovan
Paul D Kemp
Original Assignee
Organogenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organogenesis Inc filed Critical Organogenesis Inc
Application granted granted Critical
Publication of ATE276757T1 publication Critical patent/ATE276757T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Artificial Filaments (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Prostheses (AREA)
AT96923259T 1995-06-07 1996-06-07 Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung ATE276757T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48309295A 1995-06-07 1995-06-07
PCT/US1996/009861 WO1996040216A1 (en) 1995-06-07 1996-06-07 Reconstituted collagen fiber segment compositions and methods of preparation thereof

Publications (1)

Publication Number Publication Date
ATE276757T1 true ATE276757T1 (de) 2004-10-15

Family

ID=23918627

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923259T ATE276757T1 (de) 1995-06-07 1996-06-07 Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung

Country Status (10)

Country Link
US (1) US5997896A (de)
EP (1) EP0831882B1 (de)
JP (1) JP3647465B2 (de)
AT (1) ATE276757T1 (de)
AU (1) AU722322B2 (de)
BR (1) BR9609393A (de)
DE (1) DE69633444T2 (de)
ES (1) ES2229277T3 (de)
PT (1) PT831882E (de)
WO (1) WO1996040216A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7063726B2 (en) * 1998-06-30 2006-06-20 Lifenet Plasticized bone grafts and methods of making and using same
US8563232B2 (en) * 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6293970B1 (en) 1998-06-30 2001-09-25 Lifenet Plasticized bone and soft tissue grafts and methods of making and using same
US6734018B2 (en) 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US6743574B1 (en) 2000-09-12 2004-06-01 Lifenet Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6361551B1 (en) * 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
WO2001023529A1 (en) * 1999-09-28 2001-04-05 Organogenesis, Inc. Bioengineered collagen fibrils
US6592794B1 (en) 1999-09-28 2003-07-15 Organogenesis Inc. Process of making bioengineered collagen fibrils
EP1268351A1 (de) * 2000-03-06 2003-01-02 TEI Biosciences, Inc. Injizierbarer biokompatibler werkstoff und anwendungsmethoden
US7993365B2 (en) * 2001-06-08 2011-08-09 Morris Innovative, Inc. Method and apparatus for sealing access
US20070038244A1 (en) * 2001-06-08 2007-02-15 Morris Edward J Method and apparatus for sealing access
JP2003193328A (ja) * 2001-12-19 2003-07-09 Nipro Corp コラーゲン単糸の製造方法
WO2003072128A2 (en) * 2002-02-22 2003-09-04 Ebi, L.P. Methods and compositions for treating bone or cartilage defects
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US20050033157A1 (en) * 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
JP4401226B2 (ja) * 2004-04-16 2010-01-20 ミドリホクヨー株式会社 コラーゲン化粧料、その製造方法、可溶化コラーゲン繊維及びその製造装置
US20060246033A1 (en) * 2005-03-02 2006-11-02 Cook Biotech Incorporated Injectable bulking agent compositions
JP4356654B2 (ja) * 2005-06-02 2009-11-04 ニプロ株式会社 コラーゲン単糸の製造方法
US20090024224A1 (en) 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
US20090024106A1 (en) * 2007-07-17 2009-01-22 Morris Edward J Method and apparatus for maintaining access
US20090054350A1 (en) * 2007-08-23 2009-02-26 Jean-Louis Tayot Process for the sterile concentration of collagen preparations, and collagen preparations obtained
US8118832B1 (en) 2008-06-16 2012-02-21 Morris Innovative, Inc. Method and apparatus for sealing access
US8936598B2 (en) * 2009-01-14 2015-01-20 DePuy Synthes Products, LLC Spinal disc preparation tool
EP2393523A4 (de) 2009-02-06 2014-03-19 Osseous Technologies Of America Biphasische kollagenmembran oder kapsel für die geführte geweberegeneration
JP5232341B2 (ja) * 2009-06-01 2013-07-10 ミドリホクヨー株式会社 可溶化コラーゲン繊維、及びその製造方法、コラーゲン含有化粧料及びその製造方法、並びに可溶化コラーゲン繊維の製造装置
EP2467172A1 (de) * 2009-08-10 2012-06-27 Osseous Technologies Of America Selbststützender collagentunnel für gesteuerte gewebewiederherstellung und anwendungsverfahren dafür
FR2960439B1 (fr) * 2010-05-31 2012-06-15 Univ Paris Curie Matrices fibrillaires denses de collagene pour la reparation tissulaire et leur procede de preparation
US20130011451A1 (en) 2011-07-06 2013-01-10 Diversified Glogal Technologies, Llc Footbed with non-denatured collagen
US10576037B2 (en) 2012-03-14 2020-03-03 MAM Holdings of West Florida, L.L.C. Compositions comprising placental collagen for use in wound healing
WO2014121303A1 (en) 2013-02-04 2014-08-07 Northeastern University Mechanochemical collagen assembly
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
US10485521B2 (en) 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
US20170100440A1 (en) 2015-10-09 2017-04-13 MAM Holdings of West Florida, L.L.C. Amniotic fluid topical formulation
WO2017062937A1 (en) 2015-10-09 2017-04-13 Mam Holdings Of West Florida, Llc Amniotic fluid formulation for treatment of joint pain or disorder
US11273183B2 (en) 2015-10-09 2022-03-15 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of joint pain or disorders
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
US20170354692A1 (en) 2016-06-13 2017-12-14 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of lung disorders
KR102766594B1 (ko) * 2024-07-31 2025-02-12 주식회사 바이오비쥬 아텔로콜라겐을 포함하는 복합 필라멘트의 제조방법 및 이를 포함하는 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX163953B (es) * 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
US4642117A (en) * 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US5475052A (en) * 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5106949A (en) * 1989-09-15 1992-04-21 Organogenesis, Inc. Collagen compositions and methods for preparation thereof
US5378469A (en) * 1990-04-06 1995-01-03 Organogenesis, Inc. Collagen threads
AU677789B2 (en) * 1992-07-02 1997-05-08 Collagen Corporation Biocompatible polymer conjugates
US5428022A (en) * 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen

Also Published As

Publication number Publication date
US5997896A (en) 1999-12-07
ES2229277T3 (es) 2005-04-16
EP0831882B1 (de) 2004-09-22
PT831882E (pt) 2005-01-31
JP3647465B2 (ja) 2005-05-11
EP0831882A4 (de) 2000-05-03
AU722322B2 (en) 2000-07-27
DE69633444D1 (de) 2004-10-28
EP0831882A1 (de) 1998-04-01
JPH11508782A (ja) 1999-08-03
WO1996040216A1 (en) 1996-12-19
DE69633444T2 (de) 2006-02-16
AU6382196A (en) 1996-12-30
BR9609393A (pt) 1999-12-21

Similar Documents

Publication Publication Date Title
ATE276757T1 (de) Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung
BR0306846A (pt) Produto substituto do sangue, composição útil como um substituto do sangue, método para fazer um produto substituto do sangue, e, método de uso de um produto substituto do sangue para fornecer oxigênio a um tecido
DK0797609T3 (da) Polyestere
DE59510533D1 (de) Verwendung von dioxomorpholinen zur bekämpfung von endoparasiten, neue dioxomorpholine und verfahren zu ihrer herstellung
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
PT977564E (pt) Forscolina para promocao da massa corporal magra
DE69530308D1 (de) Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung
NO971568D0 (no) Analoger av keratinocyttvekstfaktor
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE203392T1 (de) Stabilisierte pseudoemulsionen und verfahren zu ihrer herstellung
DE69632194D1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
DE69715841D1 (de) Phosphatidsäure enthaltende zusammensetzungen
DE59503194D1 (de) Verfahren zur herstellung von stärkeabbauprodukten
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE69606321T3 (de) Verwendung von 2-Ethylhexyl-alpha-cyano-beta, beta-diphenylacrylat zur Verbesserung der Lichtstabilität von p-Methylbenzylidencampher
DE69734764D1 (de) Eine amidgruppe tragende schwefelhaltige verbindungen, verfahren zu ihrer herstellung, deren verwendung in medikamenten und sie enthaltende pharmazeutische zubereitungen
DE69026087D1 (de) Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DE69711633D1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
ATE182588T1 (de) Verfahen zur herstellung von (s)(+)-4, 4'-(1- methyl-1,2-ethandiyl)-bis(2,6-piperazindion
ATE191456T1 (de) Monofunktionalisierte edta-, dtpa- und ttha- derivate und deren verwendung zur herstellung von mitteln für die medizinische diagnostik oder therapie
DE50301507D1 (de) 17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
ATE206113T1 (de) Verfahren zur herstellung von substituierten 4- ethylpiperidinen
ATE121626T1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
DE59405793D1 (de) Verfahren zur herstellung c-substituierter diethylentriamine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0831882

Country of ref document: EP

REN Ceased due to non-payment of the annual fee